Caroline Baumal - Jan 16, 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Medical Officer
Signature
/s/ David Watson, attorney-in-fact for Caroline Baumal
Stock symbol
APLS
Transactions as of
Jan 16, 2024
Transactions value $
$2,453,100
Form type
4
Date filed
1/17/2024, 04:33 PM
Previous filing
Jan 5, 2024
Next filing
Jan 8, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Award $0 +25.4K +77.27% $0.00 58.4K Jan 16, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Award $2.45M +37K $66.30 37K Jan 16, 2024 Common Stock 37K $66.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents an award of Restricted Stock Units granted 01/16/2024 that vests annually from grant date over a four year period subject to continued service.
F2 This represents a stock option award granted 01/16/2024 that vests over a four year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.